Evidence map›Paper›PMID 33238944›Full record

ArticleBMC cancer2020

Toluidine blue versus frozen section for assessment of mucosal tumor margins in oral squamous cell carcinoma.

Hana'a Hezam Algadi, Amany Abd-Elhameed Abou-Bakr, Omer Mohammed Jamali, Louloua Mohamed Fathy

Registry-linked trialOpen access · goldAbstract readComparative Study
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03554967 (Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03554967 completednot on this map

Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma

TypeobservationalSponsorCairo UniversityRan2018 to 2019Enrolled30ConditionsOral Squamous Cell Carcinoma
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Fluorescent Molecular Imaging Can Improve Intraoperative Sentinel Margin Detection in Oral Squamous Cell Carcinoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Hana'a Hezam AlgadiDepartment of Oral and Maxillofacial Pathology, Faculty of Dentistry, Cairo University, Cairo, Egypt. hanaahezamalgadi@yahoo.com.ORCID http://orcid.org/0000-0001-6148-1643
Amany Abd-Elhameed Abou-BakrDepartment of Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
Omer Mohammed JamaliDepartment of Oral and Maxillofacial Surgery, Faculty of Dentistry, Cairo University, Cairo, Egypt.ORCID http://orcid.org/0000-0003-0360-7820
Louloua Mohamed FathyDepartment of Oral and Maxillofacial Pathology, Faculty of Dentistry, Cairo University, Cairo, Egypt.
Cairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhen the resected specimen is sent for intraoperative margin assessment, all margins are grossly checked, and selected margins undergo a frozen section (FS) examination. Therefore, there is a possibility of sampling error. This study evaluated the effectiveness of using toluidine blue (TB) as an intraoperative triage screening tool to detect positive mucosal margins of the resected specimens of oral squamous cell carcinoma (OSCC) and serve as a guide for FS sampling.

methodsSurgical samples of 30 consecutive patients with biopsy-proven OSCC were included in the study. A total of 140 mucosal margins were analyzed intraoperatively by TB and FS, the results were compared with the final histopathology.

resultsOf the 140 examined mucosal tumor margins, 14 stained positives with TB, six were true-positives, eight were false-positives, and there were no false-negatives, as confirmed by final histopathology of the same margins. The diagnostic performance measures were sensitivity 100.0%; specificity 94.0%; positive predictive value (PPV) 42.9%; negative predictive value (NPV) 100.0%; and accuracy 94.3% (95% CI: 89.0-97.5%). For FS, there were three true-positives, three false-negatives, and no false-positives. The diagnostic performance measures were sensitivity 50.0%; specificity 100.0%; PPV 100.0%; NPV 97.8%; and accuracy 97.9% (95% CI: 93.9-99.6%).

conclusionTB is less specific but more sensitive than FS for detecting positive mucosal margins of resected OSCC. Screening the tumor mucosal margins with TB before FS sampling may help identify more tumor-bearing margins.

trial registrationThis trial was registered at ClinicalTrials.gov. Registration number: NCT03554967 . Registration date: June 13, 2018.

Indexed as

AdultAgedCarcinoma, Squamous CellFemaleFollow-Up StudiesFrozen SectionsHumansMaleMargins of ExcisionMiddle AgedMouth NeoplasmsPrognosisProspective StudiesTolonium ChlorideYoung AdultTolonium ChlorideFrozen sectionOral CancerOral squamous cell carcinomaSurgical marginsToluidine blueTumor margins

Identifiers

PMID33238944
PMCPMC7691066
OpenAlexW3109516279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.